The current conceptualization of Alzheimer disease (AD) is driven by the amyloid hypothesis,
in which a deterministic chain of events leads from amyloid deposition and then tau …

Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …

Tau pathology is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive
aging. Using the tau PET agent 18 F-AV-1451, we examined retention patterns in cognitively …

Non-pharmacological therapies, such as physical activity interventions, are an appealing
alternative or add-on to current pharmacological treatment of cognitive symptoms in patients …

Importance The positron emission tomography (PET) tracer [ 18 F]flortaucipir allows in vivo
quantification of paired helical filament tau, a core neuropathological feature of Alzheimer …

Over the past few decades, neuroimaging has become a ubiquitous tool in basic research
and clinical studies of the human brain. However, no reference standards currently exist to …

The global epidemic of Alzheimer disease (AD) is worsening, and no approved treatment
can revert or arrest progression of this disease. AD pathology is characterized by the …

Alzheimer’s disease (AD) is characterized by the spread of tau pathology throughout the
cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals, …

… Ossenkoppele et al. employ the tracer in patients with distinct Alzheimer's disease variants
to investigate correlates of tau deposition. Pathological aggregation of tau, but not amyloid-β, …

Importance Amyloid-β positron emission tomography (PET) imaging allows in vivo detection
of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its …